SEC Form 4 · accession 0001623919-16-000041
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Gilreath
Officer — Chief Executive Officer · Director
Period of report
Mar 11, 2016
Accepted (ET)
Mar 15, 2016 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per share | Mar 11, 2016 | P | 3,200 | $4.75 | A | 3,200 | I | By Spouse |
| Common stock, par value $0.001 per share | Mar 15, 2016 | P | 1,818 | $5.50 | A | 1,818 | I | By Daughter |
| Common stock, par value $0.001 per share | holding | — | — | — | 733,250 | D | ||
| Common stock, par value $0.001 per share | holding | — | — | — | 12,243 | I | By Entrust Georgia, LLC for the benefit of Mark G. Gilreath | |
| Common stock, par value $0.001 per share | holding | — | — | — | 74,755 | I | By Mark Gregory Gilreath Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.